Efficacy and Safety of Pemetrexed and Gefitinib in the Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis

<div>Comparison of PFS between the gefitinib and pemetrexed groups in the treatment of NSCLC with wild-type EGFR.</div>

Computational and Mathematical Methods in Medicine

Figure 7: Efficacy and Safety of Pemetrexed and Gefitinib in the Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis 